Strengthening regulatory systems globally: a crucial step towards pandemic preparedness and response.
作者信息
Mukherjee Sanjana, Goodman Leah
机构信息
Center for Global Health Science and Security, Georgetown University, Washington, District of Columbia, USA
Jacobs Global Health Security, Arlington, Virginia, USA.
出版信息
BMJ Glob Health. 2023 Aug;8(8). doi: 10.1136/bmjgh-2023-012883.
Abstract
摘要
相似文献
1
Strengthening regulatory systems globally: a crucial step towards pandemic preparedness and response.全球加强监管体系：迈向大流行防范与应对的关键一步。
BMJ Glob Health. 2023 Aug;8(8). doi: 10.1136/bmjgh-2023-012883.
2
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026.全球在大流行防范和 COVID-19 方面的投资：1990 年至 2026 年的发展援助和国内卫生支出。
Lancet Glob Health. 2023 Mar;11(3):e385-e413. doi: 10.1016/S2214-109X(23)00007-4. Epub 2023 Jan 24.
3
COVID-19 calls for health systems strengthening in Africa: A case of Nigeria.新冠疫情呼唤非洲加强卫生系统建设：以尼日利亚为例。
Int J Health Plann Manage. 2021 Nov;36(6):2035-2043. doi: 10.1002/hpm.3296. Epub 2021 Aug 4.
4
Pandemic preparedness and response regulations in Finland: Experiences and implications for post-COVID-19 reforms.芬兰的大流行准备和应对法规：经验及对 COVID-19 后改革的启示。
Health Policy. 2023 Jun;132:104802. doi: 10.1016/j.healthpol.2023.104802. Epub 2023 Mar 31.
5
Health systems preparedness for COVID-19 pandemic.应对 COVID-19 大流行的卫生系统准备情况。
Indian J Public Health. 2020 Jun;64(Supplement):S91-S93. doi: 10.4103/ijph.IJPH_507_20.
6
Pandemic diseases preparedness and response in the age of COVID-19-a symposium report.《COVID-19 时代的大流行病疾病防备和应对：研讨会报告》
Ann N Y Acad Sci. 2021 Apr;1489(1):17-29. doi: 10.1111/nyas.14534. Epub 2020 Nov 5.
7
Reconceptualizing successful pandemic preparedness and response: A feminist perspective.重新构想成功的大流行病防范和应对：女性主义视角。
Soc Sci Med. 2022 Dec;315:115511. doi: 10.1016/j.socscimed.2022.115511. Epub 2022 Nov 7.
8
Public health considerations for transitioning beyond the acute phase of the COVID-19 pandemic in the EU/EEA.欧盟/欧洲经济区 COVID-19 大流行急性阶段后过渡的公共卫生考虑因素。
Euro Surveill. 2022 Apr;27(17). doi: 10.2807/1560-7917.ES.2022.27.17.2200155.
9
Primary health care response in the management of pandemics: Learnings from the COVID-19 pandemic.大流行管理中的初级卫生保健应对措施：从 COVID-19 大流行中汲取的经验教训。
Aten Primaria. 2021 Dec;53 Suppl 1(Suppl 1):102226. doi: 10.1016/j.aprim.2021.102226.
10
Optimizing Pandemic Preparedness and Response Through Health Information Systems: Lessons Learned From Ebola to COVID-19.通过卫生信息系统优化大流行防范和应对：从埃博拉到 COVID-19 的经验教训。
Disaster Med Public Health Prep. 2022 Feb;16(1):333-340. doi: 10.1017/dmp.2020.361. Epub 2020 Oct 2.
引用本文的文献
1
Strengthening Vaccine Regulation: Insights from COVID-19 Vaccines, Best Practices, and Lessons for Future Public Health Emergencies.加强疫苗监管：来自新冠疫苗的见解、最佳实践及对未来突发公共卫生事件的启示
Vaccines (Basel). 2025 Jun 12;13(6):638. doi: 10.3390/vaccines13060638.
2
Overcoming barriers to medical countermeasures: Strengthening global biosecurity.克服医学应对措施的障碍：加强全球生物安全。
Hum Vaccin Immunother. 2025 Dec;21(1):2483043. doi: 10.1080/21645515.2025.2483043. Epub 2025 Mar 25.
3
[The role of regulatory agencies within health systems during emergencies in BrazilPapel de los organismos regulatorios en los sistemas de salud en situaciones de emergencia en Brasil].[巴西紧急情况下卫生系统中监管机构的作用]
Rev Panam Salud Publica. 2024 Dec 18;48:e130. doi: 10.26633/RPSP.2024.130. eCollection 2024.
4
Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries.在低收入和中等收入国家实现单克隆抗体公平可及的新方法。
PLOS Glob Public Health. 2024 Jul 1;4(7):e0003418. doi: 10.1371/journal.pgph.0003418. eCollection 2024.
5
Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics.从 COVID-19 中吸取的教训，以降低全球南方的死亡率和发病率：为未来的大流行解决全球疫苗公平问题。
BMJ Glob Health. 2024 Jan 1;9(1):e013680. doi: 10.1136/bmjgh-2023-013680.
本文引用的文献
1
The Food and Drug Administration's (FDA's) Drug Safety Surveillance During the COVID-19 Pandemic.FDA 在新冠疫情期间的药物安全监测。
Drug Saf. 2023 Feb;46(2):145-155. doi: 10.1007/s40264-022-01256-2. Epub 2022 Dec 2.
2
Preparing Europe for future health threats and crises ─ the European Medicines Agency; ensuring safe and effective medicines and medical devices.让欧洲为未来的健康威胁和危机做好准备 ── 欧洲药品管理局；确保药品和医疗器械的安全与有效。
Euro Surveill. 2022 Oct;27(42). doi: 10.2807/1560-7917.ES.2022.27.42.2200798.
3
Pandemic preparedness and response: exploring the role of universal health coverage within the global health security architecture.大流行防范和应对：探索全民健康覆盖在全球卫生安全架构中的作用。
Lancet Glob Health. 2022 Nov;10(11):e1675-e1683. doi: 10.1016/S2214-109X(22)00341-2. Epub 2022 Sep 27.
4
How the concept of WHO-listed authorities will change international procurement policies for medicines.世界卫生组织所列权威机构的概念将如何改变药品的国际采购政策。
BMJ Glob Health. 2022 Feb;6(Suppl 3). doi: 10.1136/bmjgh-2021-008109.
5
Making the investment case for national regulatory authorities.为国家监管机构阐述投资理由。
J Pharm Policy Pract. 2021 Jan 21;14(1):16. doi: 10.1186/s40545-021-00299-7.
6
The World Health Organization Global Benchmarking Tool an Instrument to Strengthen Medical Products Regulation and Promote Universal Health Coverage.世界卫生组织全球基准工具：加强医疗产品监管和促进全民健康覆盖的工具
Front Med (Lausanne). 2020 Aug 19;7:457. doi: 10.3389/fmed.2020.00457. eCollection 2020.
Zotero 插件